Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

15450 Ventura Blvd. Suite 102
Sherman Oaks, CA 91403
Phone: 818-528-7776

December 20, 2016 by Alan Khadavi

Food Allergy Treatment Options

tree nut allergy

Food allergy treatment is being heavily researched as food allergies are becoming increasingly common.  In 2007 the estimated prevalence of food allergies among school children was 4%, an 18% increase since 1997, while other studies estimate up to 8%.  One theory why food allergies are increasing is the hygiene hypothesis. Less exposure to certain microorganisms, […]

Filed Under: Blog, Food allergy

December 1, 2016 by Alan Khadavi

Omalizumab (Xolair) for treating Angioedema and Chronic Hives

xolair for nasal polyps

Omalizumab (Xolair) is being used to treat chronic hives (urticaria).  Chronic idiopathic/spontaneous urticaria (CIU/CSU) is characterized by the spontaneous appearance of hives, angioedema or both that recur without specific external stimuli for at least 6 weeks.  Angioedema, which is the acute deeper swelling of the lower skin or subcutaneous tissue has been reported to occur […]

Filed Under: Allergy Medicine, angioedema, Blog, Urticaria

December 1, 2016 by Alan Khadavi

Canker Sores (Aphthous stomatitis)

Canker Sores (Aphthous stomatitis) is the most common inflammatory and ulcerative condition of the oral cavity.  The term aphtha is a Greek word for ulceration.  It is estimated that at least 1 in 5 individuals have been affected by canker sores (aphthous stomatitis).  The disorder most commonly affects young adults (with some studies reporting a […]

Filed Under: Blog

November 23, 2016 by Alan Khadavi

Thunderstorm Asthma kills 4

Explore how camlipixant, a selective P2X3 antagonist, reduces cough frequency and improves quality of life in patients with refractory chronic cough.

(This blog is not original content, it was adapted from the Associated Press) MELBOURNE, Australia (AP) — A rare condition known as thunderstorm asthma sent hundreds of people to hospitals in Australia’s second-largest city, and four deaths had been confirmed by Wednesday. Family confirmed Clarence Leo, a nightclub bouncer and father of two, died at […]

Filed Under: Blog, Headlines

November 17, 2016 by Alan Khadavi

Sublingual immunotherapy (SLIT) or medication for allergies?

Sublingual immunotherapy (SLIT) is being used more and more in the United States for allergic rhinitis symptoms.   Allergic rhinitis is a common condition affecting up to 500 million persons worldwide.  Allergic rhinitis is often under treated and perceived as a mild disease by physicians.  However allergies can have a a substantial adverse effect on quality […]

Filed Under: Allergy Medicine, Blog, Immunotherapy

November 15, 2016 by Alan Khadavi

How to introduce peanuts in infants

ara h 2

How to introduce peanuts is a common question asked from parents ever since the LEAP study was published. Peanut Allergy Prevention  The first step is to identify high risk infants for peanut allergy.  Before introducing peanut to high risk infants, the infant should be seen by their pediatrician if an allergist referral is required.  The allergist […]

Filed Under: Blog, Food allergy

October 25, 2016 by Alan Khadavi

Ligelizumab (QGE031) vs. Omalizumab (Xolair)

Ligelizumab (QGE031)

Ligelizumab (QGE031) is currently being developed by Novartis for the treatment of allergic diseases mainly asthma and chronic spontaneous urticaria.  Allergic diseases are dependent on the development of increased IgE levels.  Allergen-specific IgE plays a role in the inflammatory cascade of allergic responses.  Allergic individuals with elevated IgE levels have increased allergic mediators (e.g. histamine, […]

Filed Under: Allergy Medicine, Asthma, Blog, Urticaria

October 10, 2016 by Alan Khadavi

Flonase Sensimist to be available OTC

Flonase Sensimist

Update: Flonase Sensimist will be available February 2017.  It has the same active ingredient as Veramyst (fluticasone furoate and in the same strength). Flonase Sensimist is the latest nasal steroid to get approval to be sold over the counter (OTC).  Previously available as prescription only, Flonase Sensimist is for the treatment of seasonal and perennial […]

Filed Under: Allergy Medicine, Blog

October 5, 2016 by Alan Khadavi

Dupixent (Dupilumab) for Atopic Dermatitis/Eczema

dupixent

Dupixent (generic name Dupilumab) has showed great promise in a recently published study in the New England Journal of Medicine.  In a previous post, we have discussed extensively Dupilumab.  Click on the link below to read further about Dupixent (dupilumab). Dupilumab For background, atopic dermatitis or eczema, is a chronic, relapsing inflammatory skin disease that […]

Filed Under: Allergy Medicine, atopic dermatitis, Blog, Headlines

September 22, 2016 by Alan Khadavi

Hypereosinophilia (elevated eosinophil count)

nucala

Hypereosinophilia or an elevated eosinophil count can have multiple causes.  The differential list includes asthma, atopic disease, drug hypersensitivity, parasitic infections, connective tissue disorders, malignancy  (cancer) and rare hypereosinophilic disorders.  Hypereosinophilia is defined a blood eosinophil count greater than 1500 per microliter of blood and end organ damage attributable to eosinophilia.  A count of greater […]

Filed Under: biologics, Blog

  • « Previous Page
  • 1
  • …
  • 39
  • 40
  • 41
  • 42
  • 43
  • …
  • 57
  • Next Page »

alan-khadavi
Dr. Alan Khadavi
Allergy & Asthma Specialist

Latest Posts

November 17, 2026

Low Dose Naltrexone for MCAS: Benefits, Risks, and Evidence

LDN for MCAS

November 13, 2026

Cardamom Allergy: Symptoms, Diagnosis, and What to Avoid

cardamom allergy

October 28, 2026

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

October 26, 2026

Which Biologic Works Best for Nasal Polyps?

best biologic for nasal polyps

October 19, 2026

Xolair vs. Omlyclo: Cost, Effectiveness, Insurance & Switching

Xolair vs Omlyclo: Cost, Effectiveness, Insurance & Switching

October 8, 2026

Tapioca Allergy: Can Cassava Cause an Allergic Reaction?

tapioca allergy

October 8, 2026

Rhapsido for Symptomatic Dermographism: An Allergist Explains the New FDA-Approved Treatment

Rhapsido for symptomatic dermographism

October 6, 2026

Most Effective Treatments for Severe Atopic Dermatitis: New Rankings

`most-effective-treatments-severe-atopic-dermatitis

October 6, 2026

Should Airlines Be Required to Carry Epinephrine? An Allergist Explains

airline epinephrine requirement

October 2, 2026

Ketotifen for MCAS: Uses, Benefits, Side Effects, and U.S. Availability

ketotifen for MCAS

Read More Posts...

Follow Us…

© 2026 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page